Re-irradiation planning for tumors near previously treated organs
Part of Cancer clinical trials.
This study tests a more personalized way to plan “re-irradiation,” meaning giving radiation again in an area that was already treated before. It aims to better calculate organ risk to reduce harmful side effects while treating cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and be planning definitive (main) or postoperative (after surgery) high-dose radiation that overlaps a previously treated organ at risk
- Have signed consent, prior radiation dose information available, and recent baseline scans (CT, PET/CT, or MRI) within 6 weeks of starting
- Have a confirmed solid cancer diagnosis (with pathology/cytology records) and a treatment team decision that re-irradiation is recommended for your specific target area
- Be able to do required questionnaires, and have most recent cancer treatment side effects improved to mild or moderate (grade 1–2)
- Meet basic health/lab and safety limits (including blood counts and liver/kidney tests) and have an expected life span of at least 6 months
- If you can become pregnant: have a negative pregnancy test and agree to reliable birth control during the radiation course
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation, focused high-dose radiation, and an immunotherapy drug (tislelizumab) for people with large, advanced solid tumors that have not responded to standard treatments.
This study tracks patients receiving high-dose radiation therapy a second time (or more) to treat cancer that has come back or spread to a few spots. Researchers want to understand how well this approach works and what side effects patients experience.
This trial studies whether using special computer software and expert input can safely give a second round of radiation to treat cancers that have come back or spread in a limited way. It aims to offer a chance for cure when standard treatments may not work.
This trial tests a focused radiation treatment for patients who have developed a new cancer in the same breast after previous breast-conserving therapy. The goal is to safely treat the cancer while minimizing radiation to surrounding healthy tissue.
This trial tests a second round of radiation to just part of the breast for women who had a previous lumpectomy and radiation, and now have a small, early-stage cancer or DCIS in the same breast. The goal is to see if a focused re-treatment is safe and effective.
This Phase 2 study tests whether giving targeted radiation again to the same breast can control a small, local breast cancer that came back after prior whole-breast radiation. It may help some patients avoid or delay further treatment for the breast while carefully checking safety.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.